RankingsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】

Market cap
¥595B
P/E ratio
16.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025300,004-0.65%
Mar 31, 2024301,965+8.22%
Mar 31, 2023279,037+4.80%
Mar 31, 2022266,257+6.67%
Mar 31, 2021249,605+3.33%
Mar 31, 2020241,555+3.22%
Mar 31, 2019234,026+4.04%
Mar 31, 2018224,942+12.98%
Mar 31, 2017199,096+1.95%
Mar 31, 2016195,291+20.64%
Mar 31, 2015161,881+8.89%
Mar 31, 2014148,663+24.86%
Mar 31, 2013119,066+4.06%
Mar 31, 2012114,416

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)